Zbirka: Klinični preizkusi
12 rezultatov
-
-
-
-
Adverse Events - Race, Inequality, and the Testing of New Pharmaceuticals(2020) FISHER, JILL A.Vezava: Mehka41,79 €
FISHER, JILL A.
Adverse Events - Race, Inequality, and the Testing of New Pharmaceuticals
Zaloga po trgovinah
Rezultati:
-
Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines(2016) TOM BRODYVezava: Trda125,61 €
TOM BRODY
Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
Zaloga po trgovinah
Rezultati:
-
Design and Analysis of Cross-Over Trials(2014) JONES, BYRON (NOVARTIS PHARMA AG, BASEL, SWITZERLAND),KENWARD, MICHAEL G. (GSK PROFESSOR OF BIOSTATISTICS, LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE, UK)Vezava: Trda165,38 €
JONES, BYRON (NOVARTIS PHARMA AG, BASEL, SWITZERLAND),KENWARD, MICHAEL G. (GSK PROFESSOR OF BIOSTATISTICS, LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE, UK)
Design and Analysis of Cross-Over Trials
Zaloga po trgovinah
Rezultati:
-
Economic Evaluation of Cancer Drugs(2019) KHAN, IFTEKHAR,CROTT, RALPH,BASHIR, ZAHID (HAEMATO-ONCOLOGY, WELWYN GARDEN CITY, UK)The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposiVezava: Trda97,45 €
KHAN, IFTEKHAR,CROTT, RALPH,BASHIR, ZAHID (HAEMATO-ONCOLOGY, WELWYN GARDEN CITY, UK)
Economic Evaluation of Cancer Drugs
The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposi
Zaloga po trgovinah
Rezultati:
-
Sample Size Calculations in Clinical Research(2020) CHOW, SHEIN-CHUNG (DUKE UNIV, USA),SHAO, JUN (DEPARTMENT OF STATISTICS, UNIVERSITY OF WISCONSIN, USA),WANG, HANSHENG,LOKHNYGINA, YULIYA (DUKE UNIVERSITY SCHOOL OF MEDICINE, DURHAM, NC, USA)Like the well-regarded and bestselling second edition, Sample Size Calculations in Clinical Research, Third Edition, presents statistical procedures for performing sample size calculations during various phases of clinical research and development. This nVezava: Mehka73,49 €
CHOW, SHEIN-CHUNG (DUKE UNIV, USA),SHAO, JUN (DEPARTMENT OF STATISTICS, UNIVERSITY OF WISCONSIN, USA),WANG, HANSHENG,LOKHNYGINA, YULIYA (DUKE UNIVERSITY SCHOOL OF MEDICINE, DURHAM, NC, USA)
Sample Size Calculations in Clinical Research
Like the well-regarded and bestselling second edition, Sample Size Calculations in Clinical Research, Third Edition, presents statistical procedures for performing sample size calculations during various phases of clinical research and development. This n
Zaloga po trgovinah
Rezultati:
-
Real-World Evidence in Drug Development and Evaluation(2022)This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE iVezava: Mehka78,01 €
Real-World Evidence in Drug Development and Evaluation
This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE i
Zaloga po trgovinah
Rezultati:
-
Interface between Regulation and Statistics in Drug Development(2022) ALEMAYEHU, DEMISSIE,EMIR, BIROL,GAFFNEY, MICHAEL (PFIZER INC., NEW YORK)This book provides a systematic exposition of the interplay between the two disciplines, including emerging themes pertaining to the acceleration of the development of pharmaceutical medicines to serve patients with unmet needs.Vezava: Mehka78,01 €
ALEMAYEHU, DEMISSIE,EMIR, BIROL,GAFFNEY, MICHAEL (PFIZER INC., NEW YORK)
Interface between Regulation and Statistics in Drug Development
This book provides a systematic exposition of the interplay between the two disciplines, including emerging themes pertaining to the acceleration of the development of pharmaceutical medicines to serve patients with unmet needs.
Zaloga po trgovinah
Rezultati:
-
-
